All In Biotech

Drug Trial Radar · NCT00903981

Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil

A Randomized, Placebo Controlled, Double Blind, Multicenter Therapeutic Confirmatory Clinical Study for the Evaluation of the Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction

Last checked: Nov 20, 2026Latest source record: Apr 23, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 208 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

208

Actual

Start

Mar 2009

Primary completion

Oct 2009

Study completion Nov 2009

Sponsor

Lead sponsor
JW PharmaceuticalIndustry
Sponsor type
Industry
First posted
May 19, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Male only, from 19 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to confirm the efficacy and the safety of Avanafil 100mg, 200mg or placebo administered orally for 12 weeks in patients with erectile dysfunction. The efficacy is evaluated by IIEF, SEP Q2 and Q3 and GEAQ and the safety is evaluated by laboratory tests, vital signs, physical examination and adverse events.

Conditions

  • Erectile Dysfunction

Interventions

  • AvanafilDrug

    2 tablets(Avanafil 100mg tablet + Placebo 200mg tablet), 30 minutes before sexual intercourse

  • AvanafilDrug

    2 Tablets(Avanafil 200mg tablet + Placebo 100mg tablet), 30 minutes before sexual intercourse

  • PlaceboDrug

    2 Tablets(Placebo 100mg tablet + Placebo 200mg tablet), 30 minutes before sexual intercourse

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of EF domain score in the IIEF(The International Index of Erectile Function)Time frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Chonbuk national university hospital

    Jeonju, Cholabukdo, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.